Healio (5/30, Herpen) reports, “Adults with binge-eating disorder who were given acute naltrexone/bupropion performed better with similar maintenance treatment compared with placebo,” investigators concluded in a 66-adult study that in which participants were “randomized 1:1 to receive either naltrexone/bupropion (n = 32) or placebo (n = 34) for 16 weeks.” The findings were presented at the American Society of Clinical Psychopharmacology annual meeting.
Related Links:
— “Naltrexone/bupropion maintenance therapy for binge-eating disorder superior to placebo “Robert Herpen, Healio, May 30, 2023